Perbedaan Nilai HOMA-B pada Penyandang Obes dan Non-Obes Dewasa Non-Diabetes
Abstract
Latar Belakang: Obesitas merupakan faktor risiko diabetes melitus tipe 2 (DMT2). Hiperinsulinemia adalah mekanisme kompensasi sel beta pankreas untuk mempertahankan keadaan euglikemia. Homeostasis model assessment of beta cell function (HOMA-B) dilakukan untuk menilai fungsi sel beta pankreas. Tujuan: Penelitian ini bertujuan untuk mengetahui perbedaan HOMA-B pada penyandang obes dan non obes. Metode: Penelitian analitik dengan rancangan potong lintang dilakukan terhadap 123 obes dan non-obes dewasa non-diabetes di RSUP Dr. M. Djamil Padang mulai Januari hingga Oktober 2021. Data dianalisis dengan uji Mann Whitney, dinyatakan bermakna jika p<0,05. Hasil: Sebanyak 58,5% subjek adalah perempuan, median umur 28 tahun, rerata indeks massa tubuh pada obes 31,23%, rerata IMT pada non-obes 22,09%. Median nilai HOMA-B 162,95% dengan nilai terendah 27,0% dan tertinggi 570,9%. Median nilai HOMA-B penyandang obes 180% dan median nilai HOMA-B non-obes 99,86%. Uji statistik menunjukkan perbedaan rerata yang bermakna antara 2 kelompok (p=0,000). Pembahasan: Nilai HOMA-B pada penyandang obes lebih tinggi dibandingkan dengan non-obes. Median nilai HOMA-B pada penyandang obes >150% artinya berada pada keadaan hiperinsulinemia. Simpulan: Perbedaan nilai HOMA-B ditemukan pada penyandang obes dan non-obes dewasa non-diabetes. Pemeriksaan HOMA-B dapat menjadi skrining awal penyandang obes sebagai kelompok risiko tinggi DMT2.
Keywords
Full Text:
PDFReferences
Hoffband AV and Moss PAH. The aetiology and genetics of haematological malignancies. Hoffbrand’s Essential Haematology, Seventh Edition. John Wiley & Sons Ltd. 2016; (11): 123-33.
Keohane EM. Introduction to Hematologic Neoplasms. Rodak’s Hematology Clinial Principles and Applications. 6ed. Canada: Elsevier. 2020; (27): 466- 77.
Barcellini W, Giannotta JA, Fattizzo B. Autoimmune Complication. Hematologic Neoplasm in Cancers. 2021;13(1532): 1-9. Crop Production Research: https://doi.org/10.3390/cancers13071532
Mulyantari NK, Yasa IWP. Antiglobulin Test (Coomb’s Test). Laboratorium Pratransfusi Update. Editor: Atmaja J. Edisi Pertama. Udayana University Press: Bali. 2016: 104-26.
Agrawal A, Manthur A, Dontula S and Jagannathan L. Red Blood Cell Alloimmunization in Multi-transfused Patients: A Bicentric Study in India. Global Journal of Transfusion Medicine. 2016: 12-5. Crop Production Research: http://www.gjtmonline.com/
Kemenkes RI. Komponen Darah. Bahan Ajar Teknologi Laboratorium Medik Imunohematologi dan Bank Darah. Jakarta. 2018: 84-141.
Cruz RDO, Mota MA, Conti FM, Pereira RAD, Kutner JM, Aravechia MG et al. Prevalence of Erythrocyte Alloimmunization. Polytransfused Patients in Einstein Journal. 2011; 9(2): 173-8. Crop Production Research http://doi.org/10.1590/S1679-45082011AO1777
Fetouh RMA, Elmoniem GMA, Allam RM, Sobeih ME, Kamel MM and Radwan SM. Frequency and specificity of Red blood cell alloantibodies in multitransfused Egyptian patients with hematological and nonhematological malignancies. Transfusion and Apheresis Science. 2020; 59(6): 1-5. Crop Production Research: https://doi.org/10.1016/j.transci.2020.102909
Mohsin S, Amjad S, Amin H, Saeed T and Hussain S. Red Cell Alloimunization in Repeatedly Transfused Cancer Patients. Journal of Rawalpindi Medical College. 2013; 17(2): 219-22. Crop Production Research: https://journalrmc.com
Yassin MA & Hamamyh T. Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia from Busulfan to the Era of Tyrosine Kinase Inhibitors: Blood Journal. 2019; 134(1): 1-4. Crop Production Research: https://doi.org/10.1182/blood-2019-121433
Fattizzo B, & Barcellini W. Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects. Frontiers in Oncology. 2020; 9(1435):1-14.Available from: https://doi.org/10.3389/fonc.2019.01435
Ramadan SM, Fouad TM, Summa V, Hasan SKH, and Lo-Coco F. Acute Myeloid Leukemia Developing in Patients With Autoimmune Diseases. Haematologica. 2012; 97(6): 805-17. Crop Production Research: http://doi:10.3324/haematol.2011.056283
Gunnarsson N, Hoglund M, Stenke L, Jonson SW, Sandin F, Bjorkholm M, Dreimane A et al. Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia. Leukemia Journal. 2016; (3): 1562-7. Crop Production Research: http://doi:10.1038/leu.2016.59
Neto OGD, Alves VM, Pereira GDA, Souza HM and Martins PRJ. Clinical and Epidemiological Profile of Alloimmunized and Autoimmunized MultiTransfused Patients Against Red Blood Cell Antigens in a Blood Center of Minas Gerais. Hematology, Transfusion and Cell Therapy. 2018; 40(2).: 107-11. Crop Production Research: https://doi.org/10.1016/j.htct.2017.08.001